USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
MICROTRANSPONDER, INC.
Address:
2802 Flintrock Trace
AUSTIN, TX
EIN:
120857383
DUNS:
793502068
Number of Employees:
9
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,022,053.00 5
SBIR Phase II $6,757,464.00 3
STTR Phase I $113,354.00 1

Award List:

Neuro-micro-Transponders for a minimally-invasive peripheral nerve interface

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$113,354.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The MicroTransponder, Inc. technology portfolio consists of novel wireless micro- systems that are being developed as platforms for minimally invasive micro-implants for a host of biomedical applications. This plan wil l establish the feasibility of our micro-… More

Targeted Neural Plasticity for the Treatment of Tinnitus

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$239,020.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This is an application to test the feasibility of reducing tinnitus by pairing left vagus nerve stimulation (VNS) with tone presentations to reorganize the auditory cortical frequency map. Approximately ten percent of a dults experience some degree of tinnitus,… More

Novel Treatment for the Relief of Chronic Orofacial Pain

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$96,576.00
Agency:
HHS
Principal Investigator:
Richard L. Weiner
Abstract:
DESCRIPTION (provided by applicant): This is a proposal to evaluate the feasibility of using an implantable and wireless microstimulation device for reducing orofacial pain. Each year almost one sixth of the US population seeks treatment for craniofacial pain. Temporomandibular joint disorders… More

Targeted Neural Plasticity for the Treatment of Tinnitus

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$1,681,818.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In Phase I, we demonstrated the feasibility of using VNS stimulation paired with tone presentations to completely reverse the effects of tinnitus in a rat model of the disease. The Specific Aim of Phase II is to acc umulate data for the submission of an IDE… More

Enhancing Fear Extinction Using Vagus Nerve Stimulation

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$286,398.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The Specific Aim of this Phase I study is to evaluate whether vagus nerve stimulation (VNS) can enhance fear extinction. Exposure Therapy in humans is a form of fear extinction. Exposure therapy is the primary tool used to treat posttraumatic stress disorder… More

Wireless Neurostimulation for the Relief of Chronic Neuropathic and Inflammatory

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$175,016.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This is a fast-track proposal to develop a GMP biocompatible microstimulator for implantation into humans for treating chronic pain. The feasibility of using an implanted wireless microstimulator for the treatment of c hronic pain will be tested in Phase I. In… More

Wireless Neurostimulation for the Relief of Chronic Neuropathic and Inflammatory

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,505,222.00
Agency:
HHS
Principal Investigator:
Scott Armstrong – 512-913-2608
Abstract:
DESCRIPTION (provided by applicant): This is a fast-track proposal to develop a GMP biocompatible microstimulator for implantation into humans for treating chronic pain. The feasibility of using an implanted wireless microstimulator for the treatment of chronic pain will be tested in Phase I. In… More

Targeted Neural Plasticity for the Treatment of Tinnitus

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$2,570,424.00
Agency:
HHS
Principal Investigator:
Brent Tarver – 469-222-2350
Abstract:
DESCRIPTION (provided by applicant): This is a proposal to conduct a multi-center, double-blind, sham-controlled partial cross-over interventional study to test safety and efficacy of our novel tinnitus therapy. The tinnitus field generally accepts that elevated synchronous spontaneous activity in… More

Robust High-throughput Mechanical Phenotyping Platform for Clinical Diagnostics

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$225,043.00
Agency:
HHS
Principal Investigator:
Navzer Engineer – 214-280-9677
Abstract:
DESCRIPTION (provided by applicant): The Specific Aim of this proposal is to test the feasibility of using a novel method of enhancing neuroplasticity for the purpose of producing clinically significant improvements in the ability of stroke patients to perform their activities o daily living… More